drugset / Trial / NCT04967664
Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated topical application of Qutenza (capsaicin 8% topical system) versus low-dose capsaicin control (capsaicin 0.04% topical system) in subjects with moderate to severe postsurgical neuropathic pain (PSNP).
Timeline
- Start
- 2021-07-13
- Primary completion
- 2025-08-28
- Completion
- 2025-08-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capsaicin | Small molecule | 0.04 % | Topical |
| Subject | Capsaicin | Small molecule | 8 % | Topical |